PsilodexMedication × psilocybin
Your list , 0 items
Medication class

Pain relievers and psilocybin.

39 records in this group. 1 has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.

39Records
1With human data

Also searched as pain reliever · painkiller · painkillers · pain medication · pain medicine · pain pill · pain pills · pain med · analgesic

01 What the evidence covers

Best evidence available per medication
1Case reports
Case reports or online surveys
38No psilocybin data
No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts

02 Each medication

A to Z
  • Acetaminophen · TylenolEvidence: No psilocybin data

    Minor aches and pains (such as headache, toothache, backache, muscle aches, colds); Fever

    Not studied with psilocybin; no linking mechanism is described.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Acetaminophen–aspirin–caffeine · Excedrin Extra Strength, Excedrin MigraineEvidence: No psilocybin data

    Minor aches and pains (headache, colds, arthritis, muscular aches, toothache, menstrual cramps); Migraine

    Its caffeine may add to psilocybin's brief rise in heart rate. Acetaminophen and aspirin are not studied with psilocybin.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Acetaminophen–butalbital–caffeine · FioricetEvidence: No psilocybin data

    Tension (muscle contraction) headache

    Its barbiturate sedation may add to psilocybin's effects. Stopping it suddenly after regular use can cause seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Acetaminophen–codeine · Tylenol #3Evidence: No psilocybin data

    Mild to moderate pain (when an opioid is appropriate)

    Its sedation and nausea may add to psilocybin's nausea. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Acetaminophen–diphenhydramine · Tylenol PMEvidence: No psilocybin data

    Occasional headaches and minor aches and pains with accompanying sleeplessness

    It causes drowsiness and may cause confusion with psilocybin. The acetaminophen part has no known psilocybin interaction.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Aspirin · Bayer, Ecotrin, BufferinEvidence: No psilocybin data

    Minor aches and pains (headache, muscle pain, toothache, menstrual pain, arthritis); Fever

    Not studied with psilocybin; no linking mechanism is described. Also, it raises bleeding risk, more so with blood thinners or steroids.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Buprenorphine · Suboxone, Zubsolv, Sublocade, BrixadiEvidence: Case reports

    Opioid use disorder (opioid dependence)

    In two people on buprenorphine, psilocybin was tolerated without serious events. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • ButorphanolEvidence: No psilocybin data

    Pain severe enough to require an opioid when other treatments are inadequate; Before surgery or anesthesia, and as a supplement to balanced anesthesia (injection)

    Its label reports possible unpleasant dreamlike mental effects, which may add to psilocybin's. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Celecoxib · Celebrex, ElyxybEvidence: No psilocybin data

    Osteoarthritis; Rheumatoid arthritis

    Not studied with psilocybin. Also, long-term use can raise blood pressure, and its label has a boxed warning for heart attack and stroke.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • CodeineEvidence: No psilocybin data

    Mild to moderate pain when an opioid is appropriate

    Its sedation and nausea may add to psilocybin's nausea. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Diclofenac · Voltaren, CambiaEvidence: No psilocybin data

    Osteoarthritis; Rheumatoid arthritis

    Lab studies suggest it may slow how the body clears psilocybin (not shown in people), and its blood pressure rise may add to psilocybin's.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Fentanyl · DuragesicEvidence: No psilocybin data

    Severe long-term pain in opioid-tolerant patients

    This opioid can slow breathing and psilocybin does not; serotonin effects may add. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Hydrocodone–acetaminophen · NorcoEvidence: No psilocybin data

    Pain severe enough to require an opioid

    Its sedation and nausea may add to psilocybin's; its breathing risk rises with other sedatives. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Hydromorphone · DilaudidEvidence: No psilocybin data

    Severe pain requiring an opioid when other treatments are inadequate

    It may add nausea to psilocybin's and causes sedation and slowed breathing, which psilocybin does not. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Ibuprofen · Advil, MotrinEvidence: No psilocybin data

    Minor aches and pains (headache, toothache, backache, muscle aches, minor arthritis pain, colds); Menstrual cramps

    Not studied with psilocybin. Also, daily use can raise blood pressure.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Ibuprofen–diphenhydramine · Advil PM, Motrin PMEvidence: No psilocybin data

    Occasional sleeplessness associated with minor aches and pains

    Its diphenhydramine causes drowsiness and may cause confusion under psilocybin. Also, regular ibuprofen use can raise blood pressure, as psilocybin briefly does.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Indomethacin · Indocin, TivorbexEvidence: No psilocybin data

    Rheumatoid arthritis; Ankylosing spondylitis

    Not studied with psilocybin; it can raise blood pressure, so a combined rise is possible. Also, it may worsen depression and rarely cause psychotic episodes.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Ketorolac · ToradolEvidence: No psilocybin data

    Short-term (up to 5 days) moderately severe acute pain

    Not studied with psilocybin, and no effect on how the body clears psilocybin has been identified.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • LevorphanolEvidence: No psilocybin data

    Pain severe enough to require an opioid when other treatments are inadequate

    Its sedation and nausea may add to psilocybin's; it can slow breathing, which psilocybin does not. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • LidocaineEvidence: No psilocybin data

    Pain after shingles (post-herpetic neuralgia) (5% patch); Local or regional anesthesia by infiltration or peripheral nerve block (injection)

    Not studied with psilocybin; no linking mechanism is described. Also, skin forms are barely absorbed; high blood levels from injection can cause confusion or seizures.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Mefenamic acid · PonstelEvidence: No psilocybin data

    Mild to moderate pain (short-term, up to 1 week); Menstrual cramps (primary dysmenorrhea)

    In lab studies it slowed how the body clears psilocybin, so it may raise psilocybin levels and add to its blood pressure rise.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Meloxicam · MobicEvidence: No psilocybin data

    Osteoarthritis; Rheumatoid arthritis

    Not studied with psilocybin; no linking mechanism is described. Also, long-term use can raise blood pressure.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Meloxicam–rizatriptan · SymbravoEvidence: No psilocybin data

    Migraine attacks (acute treatment)

    Not studied with psilocybin; both parts can raise blood pressure and one acts on serotonin, so added effects are possible.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Meperidine · DemerolEvidence: No psilocybin data

    Severe pain requiring an opioid; Pain control before and during surgery (preoperative medication, anesthesia support)

    Not studied with psilocybin; it has serotonin-boosting activity, so added serotonin effects are possible. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Methadone · MethadoseEvidence: No psilocybin data

    Severe, persistent pain requiring an opioid; Opioid use disorder (detoxification and maintenance treatment)

    Not studied with psilocybin; it is sedating and mildly serotonin-boosting, so added effects are possible. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Morphine · MS ContinEvidence: No psilocybin data

    Severe, persistent pain requiring an opioid when alternatives (including immediate-release opioids) are inadequate (extended-release tablets); Pain severe enough to require an opioid when alternatives are inadequate (injection)

    Its sedation and nausea may add to psilocybin's effects; slowed breathing is its own risk. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Nabumetone · RelafenEvidence: No psilocybin data

    Osteoarthritis (signs and symptoms); Rheumatoid arthritis (signs and symptoms)

    Not studied with psilocybin; no linking mechanism is described. Also, long-term use can cause or worsen high blood pressure.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • NalbuphineEvidence: No psilocybin data

    Pain severe enough to require an opioid when other treatments are inadequate; Supplement to balanced anesthesia

    Not studied with psilocybin; it is sedating and its label reports hallucinations, so added effects are possible. Also, it can trigger opioid withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Naproxen · Aleve, NaprosynEvidence: No psilocybin data

    Minor aches and pains (headache, toothache, backache, muscle aches, minor arthritis pain, colds); Menstrual cramps

    Not studied with psilocybin; no linking mechanism is described. Also, daily use can raise blood pressure.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Naproxen–diphenhydramine · Aleve PMEvidence: No psilocybin data

    Occasional sleeplessness associated with minor aches and pains

    It causes drowsiness and may cause confusion with psilocybin; regular naproxen use can raise blood pressure, as psilocybin briefly does.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Oliceridine · OlinvykEvidence: No psilocybin data

    Acute pain severe enough to require an intravenous opioid when other treatments are inadequate (adults)

    Not studied with psilocybin; this hospital opioid sedates and slows breathing, which psilocybin does not. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Oxycodone · Roxicodone, OxyContinEvidence: No psilocybin data

    Pain severe enough to require an opioid when other treatments are inadequate (immediate-release); Severe, persistent pain needing long-term daily opioid treatment (extended-release)

    Its sedation and nausea may add to psilocybin's effects; slowed breathing is its own risk. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Oxycodone–acetaminophen · PercocetEvidence: No psilocybin data

    Pain severe enough to require an opioid when other treatments are inadequate

    Its sedation and nausea may add to psilocybin's effects; slowed breathing is its own risk. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • OxymorphoneEvidence: No psilocybin data

    Acute pain severe enough to require an opioid when other treatments are inadequate (immediate-release); Severe, persistent pain needing an opioid that other options cannot treat (extended-release)

    Its sedation and nausea may add to psilocybin's effects; slowed breathing is its own risk. Stopping it suddenly after regular use can cause withdrawal.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Pentazocine (with naloxone)Evidence: No psilocybin data

    Pain severe enough to require an opioid when other treatments are inadequate

    Not studied with psilocybin. Its label reports hallucinations and raised blood pressure, so added effects on perception and blood pressure are possible.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Sumatriptan–naproxen · TreximetEvidence: No psilocybin data

    Acute treatment of migraine with or without aura (adults and children 12 and older)

    Sumatriptan's serotonin activity may add to psilocybin's effects and brief blood pressure rise. Also, its label reports rare significant blood pressure rises.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Suzetrigine · JournavxEvidence: No psilocybin data

    Moderate to severe acute pain in adults

    Not studied with psilocybin; it speeds up an enzyme that helps clear psilocybin, so slightly lower levels are possible.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Tapentadol · NucyntaEvidence: No psilocybin data

    Acute pain severe enough to require an opioid; Severe persistent pain requiring an opioid (extended-release)

    It may add serotonin effects to psilocybin and make seizures more likely. As an opioid it causes sedation and slowed breathing, which psilocybin does not.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Tramadol · UltramEvidence: No psilocybin data

    Pain severe enough to require an opioid (adults)

    It may add serotonin effects to psilocybin or weaken it, and can cause seizures. As an opioid, it slows breathing; psilocybin does not.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

03 Properties the records flag

Records with each flag
23Sedating or CNS depressant
21Serotonergic
20Lowers seizure threshold or carries seizure risk
20Withdrawal or rebound if stopped abruptly
19Lowers blood pressure or causes orthostasis
19Opioid
15Raises blood pressure or heart rate
9Liver injury
4Psychiatric reactions
3Anticholinergic
3Opioid blocker
3QT-prolonging
1Dehydration or electrolyte risk
1Hypoglycemia risk
1Slows gastric emptying
1Speeds up drug metabolism
1UGT inhibition (theoretical effect on psilocin levels)

Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.

04 State rules

Official text governs
COColorado · final · checked 2026-10-24

No provision names these medications or this group.

Rule 2.2(A)(9): a facilitator must tell prospective participants in writing that anyone taking a psychotropic medication identified as a risk factor on the safety screen must meet one of the 2.2(A)(7) conditions. 1 of the 39 medications in this group is psychotropic; the rule applies when one is identified as a risk factor on a participant's screen.

OROregon · final · checked 2026-10-24

No provision names these medications or this group.

NMNew Mexico · pending · checked 2026-10-24

Rules not final; the proposed rules reviewed name no medication in this group.

05 Studies cited in this group

Records citing each
20Halman A, Kong G, Sarris J, Perkins D. Drug–drug interactions involving classic psychedelics: a systematic review. J Psychopharmacol 2024;38(1):3–18.
19Sarparast A, Thomas K, Malcolm B, Stauffer CS. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology 2022;239(6):1945–1976.
2Thomann J, Kolaczynska KE, Stoeckmann OV, et al. In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin. Front Pharmacol 2024;15:1391689.
1Manevski N, Kurkela M, Höglund C, et al. Glucuronidation of psilocin and 4-hydroxyindole by the human UDP-glucuronosyltransferases. Drug Metab Dispos 2010;38(3):386–395.
1Nicholas CR, Horton DM, Malicki J, et al. Psilocybin for opioid use disorder in two adults stabilized on buprenorphine: a technical report on study modifications and preliminary findings. Psychedelic Med 2023;1(4):253–261.

Related classes

Records reviewed 2026-09-30 to 2026-10-25. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z

AgreementPsilodex

Before you use Psilodex

Check each box to continue.

Your searches, your list and the medications you look up stay in this browser. We can't see them. Privacy · Emergency: 911 · Mental health crisis: call or text 988 · Poison Control: 1-800-222-1222

Terms version 2026-10-25